Hims & Hers Health (HIMS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Jun, 2026Opening remarks and agenda
CEO welcomed stockholders, directors, officers, employees, auditors, and counsel to the virtual meeting and outlined the agenda, including formal matters, voting, and a Q&A session.
Board and executive committee updates
Nine directors were nominated for election to serve a one-year term or until successors are elected and qualified.
Shareholder proposals
Three formal business items were presented: election of directors, ratification of the independent auditor, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Hims & Hers Health
- 2030 targets hinge on global expansion, specialty growth, and AI-driven platform leadership.HIMS
2026 Evercore Global TMT Conference2 Jun 2026 - Rapidly scaling personalized health platform targets $6.5B+ revenue by 2030.HIMS
Investor presentation29 May 2026 - Q1 2026 revenue up 4% to $608.1M; net loss widened on restructuring, but guidance raised.HIMS
Q1 202618 May 2026 - Proxy covers director elections, auditor ratification, and executive pay, highlighting strong growth and governance.HIMS
Proxy filing28 Apr 2026 - Votes sought for nine directors, auditor ratification, and executive pay at June 2026 meeting.HIMS
Proxy filing28 Apr 2026 - Personalized care, tech-driven growth, and global expansion fuel strong revenue and margin outlook.HIMS
Morgan Stanley Technology, Media & Telecom Conference 20262 Mar 2026 - 2025 revenue up 59% to $2.35B, with strong subscriber and specialty growth, and robust 2026 outlook.HIMS
Q4 202524 Feb 2026 - Q2 revenue up 52% to $315.6M, net income $13.3M, strong subscriber and margin growth.HIMS
Q2 20242 Feb 2026 - Personalized, tech-driven healthcare and GLP-1s fuel rapid growth and operational gains.HIMS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026